Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Pneumonitis
ADR ID BADD_A03482
ADR Hierarchy
22      Respiratory, thoracic and mediastinal disorders
22.01      Lower respiratory tract disorders (excl obstruction and infection)
22.01.01      Lower respiratory tract inflammatory and immunologic conditions
22.01.01.006      Pneumonitis
Description A disorder characterized by inflammation focally or diffusely affecting the lung parenchyma. [CTCAE] Infection of the lung often accompanied by inflammation. | Inflammation of any part, segment or lobe, of the lung parenchyma. [MeSH]
MedDRA Code 10035742
MeSH ID D011014
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Pneumonitis | Pneumonitis NOS | Pulmonitis | Lung inflammation | Chronic pneumonitis | Obstructive pneumonitis | Noninfectious pneumonitis | Pneumonia | Pneumonias | Lobar Pneumonia | Lobar Pneumonias | Pneumonias, Lobar | Pneumonia, Lobar | Experimental Lung Inflammation | Experimental Lung Inflammations | Inflammation, Experimental Lung | Lung Inflammation, Experimental | Lung Inflammations, Experimental | Pneumonitides | Pulmonary Inflammation | Inflammation, Pulmonary | Inflammations, Pulmonary | Pulmonary Inflammations | Lung Inflammation | Inflammation, Lung | Inflammations, Lung | Lung Inflammations
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02253Trabectedin0.000336%
BADD_D02257Trametinib0.000448%
BADD_D02258Trametinib dimethyl sulfoxide--
BADD_D02276Triamterene hydrochlorothiazide--
BADD_D02334Vandetanib0.000168%
BADD_D02344Vemurafenib0.000336%
BADD_D02345Venetoclax0.000526%
BADD_D02363Vinorelbine0.000112%
BADD_D02365Vismodegib0.000168%
BADD_D02369Voriconazole0.014521%
BADD_D02412Octreotide0.000279%
BADD_D02443Tiotropium0.000213%
BADD_D02453Midostaurin0.000504%
BADD_D02470Nintedanib0.000280%
BADD_D02480Alectinib0.001086%
BADD_D02482Acalabrutinib0.000280%
BADD_D02483Ribociclib0.002071%
BADD_D02487Baricitinib0.000241%
BADD_D02498Abemaciclib0.003067%
BADD_D02500Alpelisib0.002753%
BADD_D02504Lorlatinib0.001186%
BADD_D02509Brigatinib0.000862%
BADD_D02520Baloxavir marboxil0.000282%
BADD_D02540Capmatinib0.000716%
BADD_D02544Copanlisib0.000246%
BADD_D02553Entrectinib0.000302%
BADD_D02566Lurbinectedin0.000168%
BADD_D02573Mobocertinib0.000168%
BADD_D02585Pralsetinib0.000392%
BADD_D02593Selpercatinib0.000112%
The 5th Page    First    Pre   5 6    Next   Last    Total 6 Pages